Comments on: AstraZeneca cancer medicine fails to meet main objective https://ukinvestormagazine.co.uk/astrazeneca-cancer-medicine-fails-to-meet-main-objective/ UK Investor Magazine provides breaking financial news and investment ideas Fri, 14 Dec 2018 10:12:58 +0000 hourly 1 https://wordpress.org/?v=6.8.5 By: ReNeuron shares rally despite first-half loss - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-cancer-medicine-fails-to-meet-main-objective/#comment-9049 Fri, 14 Dec 2018 10:12:58 +0000 https://ukinvestormagazine.co.uk/?p=16345#comment-9049 […] in the medical sector, AstraZeneca’s cancer medicine failed to meet its primary objective in November. Equally, the company sold its US rights to Sobi and […]

]]> By: C4X Discovery and E-Therapeutics Parkinson’s treatment development, shares rise - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-cancer-medicine-fails-to-meet-main-objective/#comment-8980 Thu, 06 Dec 2018 11:55:36 +0000 https://ukinvestormagazine.co.uk/?p=16345#comment-8980 […] in the pharmaceutical sector, AstraZeneca’s cancer medicine failed to meet its main objectives. Additionally, the company revealed its earnings in the third quarter, outlining its Brexit […]

]]>